Pharma & Biotech

Shares of Dr. Reddy’s Laboratories are attracting investor attention, bolstered by the company's deliberate strategy in high-value complex generics and...

Investor sentiment toward Eli Lilly turned cautious last week, with the pharmaceutical giant's stock declining approximately 4.5% over a five-day...

Shares of AI-driven biotechnology firm Absci experienced significant volatility following a key development in its research pipeline. The catalyst was...

Market analysts are projecting substantial growth potential for Cullinan Oncology LLC (CLNN), with a consensus price target suggesting a potential...

Shares of genome-editing company Intellia Therapeutics closed the trading week in negative territory, continuing a period of pronounced weakness. The...

The biotechnology firm CureVac is approaching its final days as a publicly traded company on the NASDAQ. The acquisition by...

Shares of the biotechnology firm Allogene Therapeutics experienced a notable decline during the previous trading session. The move lower occurred...

While BioNTech SE achieved a major strategic objective this week, investor sentiment was dominated by emerging regulatory headwinds from the...

A dramatic power struggle is unfolding at ophthalmic device maker Staar Surgical, casting severe doubt over its pending acquisition by...

The pharmaceutical giant Teva is currently charting a remarkable recovery narrative. Having navigated years of consolidation and debt reduction, the...